Glenmark Looking To Raise $200 Million


Glenmark, a major Indian generic pharma manufacturer, is looking to raise $200 million in order to grow its research and development operation, expand its manufacturing capability, and to reduce company debt. Glenmark already has a partner in International Finance Corporation, which has pledged an investment of up to $75 million. Much of the expansion will be focused on supporting Glenmark’s growth in domestic manufacturing with increases in capital expenditures at Indian facilities. The manufacturing growth could help with new product launches in cardiology, diabetes, and respiratory over the next several years.

Read the source article at Business-Standard

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>